SCHEMBL7368151

SCHEMBL7368151

COc1cc(C(=O)CC(=O)c2ccccc2O)cc([N+](=O)[O-])c1OC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.62
MEN1 O00255 3/20 0.62
MAPT P10636 3/20 0.62
KMT2A Q03164 3/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
GAA P10253 1/20 0.62
NPC1 O15118 5/20 0.53
IDO1 P14902 1/20 0.48
TDO2 P48775 1/20 0.48
TPMT P51580 1/20 0.48
KCNMA1 Q12791 2/20 0.47
ABCB1 P08183 2/20 0.47
ABCC1 P33527 1/20 0.47
MAPK1 P28482 1/20 0.47
RAB9A P51151 2/20 0.46
KDM4E B2RXH2 2/20 0.45
LMNA P02545 2/20 0.45
HPGD P15428 2/20 0.45
ALOX12 P18054 2/20 0.45
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9530950 0.88 KMT2A (0.75) ALDH1A1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL7364411 0.80 TTR (0.60) ALDH1A1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL8729017 0.80 TPMT (0.54) ALDH1A1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL29149105 0.79 KMT2A (0.73) ALDH1A1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL8406620 0.78 KMT2A (0.56) ALDH1A1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL311717 0.77 NPC1 (0.60) ALDH1A1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL8109202 0.77 TPMT (0.52) ALDH1A1MEN1KMT2AGAATPMT
SCHEMBL29149100 0.77 KMT2A (0.70) ALDH1A1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL1447632 0.76 TPMT (0.51) ALDH1A1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL7368574 0.75 TUBB4A (0.57) ALDH1A1MAPTSMN1; SMN2TPMTABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed